Table 17.2Early discharge criteria and rates

Study IDPopulationCancerStudy periodEpisodes febrile neutropeniaNumber of patientsCriteria for dischargeNo. meeting basic criteria for early dischargeNo. discharged earlyHospital re-admission in early discharge groupDeath in early discharge group
Randomised Controlled trials
1. Innes 2003AdultHaematologic and solid malignancies1997-2000102126Anticipated duration of neutropenia < 7 days

Haemodynamically stable

No signs or symptoms that required IV fluid support

Adequate renal function

Ability to maintain satisfactory oral intake

Living with responsible adult prepared to act as a carer

Patient or carer able to read a thermometer
N.A.N.A.5 (13%)0 (0%)
2. Santolaya 2004PaediatricHaematologic and solid malignancies2000 -2003390390Serum C-reactive protein (CRP) levels lower 90 mg/L

No hypotension

No relapse of leukaemia as cancer type

Platelet count of more than 50,000/μL

No recent (≤ 7 days) chemotherapy
N.A.N.A.Not reported0 (0%)
Open un-randomised comparative study
3. Lau 1994Paediatric1990-19912123Negative blood cultureN.A.11 (only considered low risk patients)Not reported by group0 (0%)
Prospective case series
4. Cherif 2006AdultHaematologic malignancies2003-2005279191MASCC (score ≥ 21)

Afebrile for 24 hours

Discharged with oral antibiotics
105 (38%)67 (24%)3 (4%)0 (0%)
5. Girmenia 2007AdultHaematologic malignancies2001-200210087MASCC (score ≥ 21)

Afebrile for 48 hours

Discharged with oral antibiotics
90 (90%)69 (69%)2 (3%)0 (0%)
6. Klastersky 2006AdultHaematologic and solid malignancies1999-2003611441MASCC (score ≥ 21)

Hospitalised for minimum of 24 hours

Discharged with oral antibiotics
383 (63%)79 (13%)3 (4%)0 (0%)
7. Nijhuis 2005Adult and PaediatricHaematologic and solid malignancies1999-2002196128No local bacterial infection / abnormal vital signs (systolic blood pressure less than 99 mmHg, or both heart rate higher than 100/min in adults or less than -2SD for age in children and respiratory rate higher than 20/min in adults or both heart and respiratory rate higher than +2 SD for age in children suggesting sepsis.

Interleukin 8 level below cut off value of 60 ng/L

Antibiotics completely withheld.

Afebrile for 12 hours
36 (18%)36 (18%)0 (0%)0 (0%)
8. Dommett 2009PaediatricHaematologic and solid malignancies2004-2005762368Excluded from low risk protocol if: Age<1 year, shock/ compensated shock, haemorrhage, dehydration, metabolic instability, altered mental status, pneumonitis, mucositis, respiratory distress/ compromise, peri-rectal / other soft tissue abscess, rigors, irritability/meningism, organ failure, acute lymphoblastic leukaemia at diagnosis/relapse <28 d, acute lymphoblastic leukaemia not in remission >28 d acute myeloid leukaemia, infant acute lymphoblastic leukaemia, intensive B-NHL protocols, haemopoietic stem cell transplant, sequential high dose chemotherapy with PBSC rescue, intensive care admission during last FN episode, non adherence (social concerns or patient), inability to tolerate oral antibiotics, positive blood culture result at 48 h, ANC < 0.1 · 109/L at 48 h, child not clinically well at 48 h (clinician judgement).

Hospitalised for minimum of 48 hours

Discharged with oral antibiotics
212 (27%)143 (19%)8 (6%)0 (0%)
9. Lehrnbecher 2002PaediatricHaematologic and solid malignancies1994-199610656Patients were not formally categorised as high / low risk. Were eligible for discharge when following criteria met: good clinical condition, negative blood culture results, no infectious focus, absence of fever for at least 24 hrs. Early discharge only allowed in cases of fever of unknown origin

Hospitalised for minimum of 72 hours. Afebrile for 24 hours.

Antibiotics ceased before discharge
N/A24 (23%)0 (0%)0 (0%)
10. Bash 1994PaediatricHaematologic and solid malignancies1989-199013174Appeared clinically well

Negative blood cultures

Exhibited control of local infection

Hematologic evidence of bone marrow recovery

Antibiotics ceased before discharge
82 (63%)78 (58%)7 (9%)*


*these patients said to violate the early discharge protocol
0 (0%)
Retrospective case series
11. Tordecilla 1994PaediatricSolid malignancies1992-19938450*retrospective analysis, patients were not prospectively assigned to low/high risk groups

Appeared well

Negative blood cultures

Normal chest x-ray

Afebrile

Discharged with/ without antibiotics
N.A.30 (35.7%)0 (0%)0 (0%)
12. Aquino 1997PaediatricHaematologic and solid malignancies1992 -1995580253*retrospective analysis, patients were not prospectively assigned to low/high risk groups

Clinically well appearance

Sterility of all blood cultures

Control of local infection with antibiotic therapy (defined as reduction or resolution of local signs of inflammation such as erythema, induration and tenderness)

Evidence of bone marrow recovery (defined as any sustained increase in platelet count and ANC or APC)

Afebrile for 24 hours

Discharged with/without oral antibiotics
N.A.330 (57%)21 (6%)0 (0%)
13. Mullen 1990PaediatricHaematologic and solid malignancies1988-199911461*retrospective analysis, patients were not prospectively assigned to low/high risk groups

Negative blood cultures

(Usually) some evidence of bone-marrow recovery

Afebrile for 1-2 days
N.A.77 (68%)3 (3.9%)0 (0%)
14. Griffin 1992PaediatricHaematologic and solid malignancies198910764Initial blood cultures were sterile after 48 hours

Appeared well

Any identified infection is under control

Afebrile for 24 hours
N.A70 (65%)1/70 (1%)0 (0%)
15. Wacker 1997PaediatricHaematologic and solid malignancies1992-19958830*retrospective analysis, patients were not prospectively assigned to low/high risk groups

No documented infection (no pathogenic organisms identified on cultures) throughout hospital course

Normal physical exam

Afebrile for 24 hours
44 (50%)25 (28%)2 (8%)0 (0%)
16. Hodgson-Viden 2005PaediatricHaematologic and solid malignancies1997 -2002276127*retrospective analysis, patients were not prospectively assigned to low/high risk groups

No formal criteria for early discharge. Decision based solely on clinician's judgement.

Patients were discharged on the day intravenous antimicrobial therapy (IVAMT) was ceased. Early discharge was defined as discontinuation of IVAMT with an ANC ≤ 500/mm3.
N.A.112 (41%)0 (0%)0 (0%)
17. Tomiak 1994AdultHaematologic and solid malignancies1991-1993134134*retrospective analysis, patients were not prospectively assigned to low/high risk groups

Negative blood cultures

Afebrile and clinically stable for 48 hours
N.A.37 (28%)2 (5%)1 (3%)
18. Santos-Muchado 1999PaediatricHaematologic and solid malignancies19967946Negative blood cultures

Afebrile for 24 hours

Discharged with oral antibiotics (in most cases)
N.A.34 (43%)Not reported0 (0%)

From: Subsequent Treatment: guideline chapter seven

Cover of Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
NICE Clinical Guidelines, No. 151.
National Collaborating Centre for Cancer (UK).
Copyright © National Collaborating Centre for Cancer, 2012.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.